Product
TD-1473
Aliases
TD-1473 Dose A, TD-1473 Dose B, TD-1473 Dose C
3 clinical trials
2 indications
Indication
Ulcerative ColitisIndication
Crohn's diseaseClinical trial
A 3-Year, Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety and Tolerability of TD-1473 in Subjects With Ulcerative Colitis (UC)Status: Terminated, Estimated PCD: 2021-10-27
Clinical trial
A Phase 2b/3 Multi-Center, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled, Parallel-Group Set of Studies to Evaluate the Efficacy and Safety of Induction and Maintenance Therapy With TD-1473 in Subjects With Moderately-to-Severely Active Ulcerative ColitisStatus: Terminated, Estimated PCD: 2021-10-20
Clinical trial
A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo˗Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Induction Therapy With 2 Doses of TD-1473 in Subjects With Moderately-to-Severely Active Crohn's DiseaseStatus: Terminated, Estimated PCD: 2021-12-30